Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Nutra’s category mix in September 2026 tilted toward Topical at 52.12% share, while Capsules held 47.70% and Edible was 0.18%. Within the month, Topical declined by 25.32% MoM and 26.40% YoY, whereas Capsules rose 15.92% MoM and 19.10% YoY; Edible rebounded 35.43% MoM but fell 61.87% YoY. Despite brand-level sales down 10.18% YoY and an 8.23% YoY lift in average price to $42.95, the simultaneous share-weighted pullback in Topical and expansion in Capsules signals an active rebalancing away from a contracting anchor toward a growing pillar.
These shifts imply Nutra is repositioning from a Topical-led profile toward a dual-pillar stance where Capsules supplies incremental stability, supported by a 19.10% YoY gain even as Topical contracts 26.40%. Holding rank 4 in Topical in British Columbia while Topical’s MoM drop is 25.32% and Capsules’ MoM gain is 15.92% suggests near-term share defense in Topical depends on mix discipline, and medium-term growth likely hinges on accelerating Capsules to offset Topical volatility.
Competitive Landscape
Nutra is ranked #4 in BC Topical in September 2026, unchanged YoY at #4 but down one position from a peak of #3 in August 2026, while category leader Proofly held at #1 YoY with a -7.34% sales change and Wildflower climbed from #5 to #3 with a 61.66% YoY sales increase. Against this backdrop, Stewart Farms stayed at #2 despite a -21.04% YoY sales decline, and Wildflower Canada fell from #3 to #5 with a -44.57% YoY drop, indicating that Nutra’s flat YoY rank at #4 alongside a slip from #3 in August 2026 implies pressure from faster-rising peers above and softening incumbents that Nutra has not converted into share gains.

Notable Products
CBD Isolate Capsules 60-Pack (6000mg CBD) posted the largest month-over-month surge at +334.9% and climbed to rank 3, while the rank 1 CBD Peppermint Lavender + MAG + Hyaluronic Acid Balm (3000mg CBD) fell -25.3% and the rank 4 CBD/CBG 5:1 Harmony Blend Relief Stick (1000mg CBD, 200mg CBG) declined -38.9%. Capsules concentrated the leaderboard with seven of the top ten, including a +246.2% jump for the rank 7 CBD/CBG 5:1 Sunbeam Capsules 30-Pack (3000mg CBD, 600mg CBG) alongside a -49.6% drop for the rank 6 CBD Isolate Capsules 15-Pack (1500mg CBD). The coexistence of triple-digit capsule gains next to double-digit topical declines, despite the topical leader generating $49,098, indicates a pivot in buyer preference toward higher-dosage and blended cannabinoid capsule formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







